Latest Videos |view all videos
Video
Roswell Park Welcomes New Director of Nuclear Medicine: Jean-Luc Urbain, MD, PhD, FASNC
Jean-Luc Urbain, Md, PhD, FASNC, a renowned expert in the field of theranostics and nuclear medicine, is joining Roswell Park Comprehensive Cancer Center as the Director of Nuclear Medicine.
Video
The New York State Cellular Therapy Consortium
Hosted by Roswell Park Comprehensive Cancer Center | Thursday, May 25, 2023 | 6-8 p.m.
Video
100th robotic Ivor Lewis esophagectomy: Important milestone for complex procedure
Roswell Park’s Moshim Kukar, MD, recently completed his 100th robotic Ivor Lewis esophagectomy, an important milestone for this complex procedure. While robotic surgery is increasingly common for other types of operations, few centers ...
Video
Roswell Park Welcomes New Vice Chair of Clinical Affairs: Dr. Peter Maslak
Peter Maslak, MD, is an expert Hematologic Oncologist, joining Roswell Park as Vice Chair of Clinical Affairs, Director of Flow Cytometry in the Immune Monitoring Shared Resource and the Technical Director of the Flow Cytometry Lab.
Video
Chronic Opioid Use Reduced by Limiting Prescribed Opioids After Surgery
Research at Roswell Park Comprehensive Cancer Center shows that putting a three-day limit on opioid prescriptions to treat surgical pain after hospital discharge reduces the number of patients who become chronic opioid users without compromising ...
Video
Roswell Park Welcomes New Chief of Lymphoma Clinical Section: Dorothy Pan, MD
Dorothy Pan, MD, is joining Roswell Park Comprehensive Cancer Center as the Chief of the Lymphoma Clinical Section in the Department of Medicine.
Video
Roswell Park Researchers Present New Approach to Understanding Challenging CAR T-Cell Toxicities
Roswell Park Comprehensive Cancer Center pre-doctoral trainee Payal Goala, MS, BS, presented research findings that hold potential to help address two significant toxicities associated with Chimeric Antigen Receptor (CAR) T-cell therapy.
Video
VHL Syndrome Q&A with Roswell Park Comprehensive Cancer Center
VHL (von Hippel-Lindau disease) is a rare genetic disease that can cause tumors, both benign and malignant, to develop in up to ten different organs throughout a patient's life.
BROADCASTMED